Esomin-L
Esomin-L Products are primarily used for
Gastroesophageal reflux disease (Acid reflux), Peptic ulcer disease
About Esomin-L Products
Uses of Esomin-L Products
Levosulpiride+Esomeprazole is used in the treatment of gastroesophageal reflux disease (acid reflux) and peptic ulcer disease.
Esomin-L Products side effects
Common
Side Effects of Esomin-L are Nausea, Vomiting, Diarrhea, Headache, Flatulence, Abdominal pain, Dizziness, Joint pain, Drowsiness, Absence of menstrual periods, Breast enlargement in male, Unusual production of breast milk in women and men, Altered libido.
How Esomin-L Products work
Levosulpiride + Esomeprazole is a combination of two medicines: Levosulpiride + Esomeprazole1 and Levosulpiride + Esomeprazole2.
Patient Concerns about Esomin-L Products
Frequently asked questions about Esomin-L Products
Frequently asked questions about Esomin-L Products
Q. What are the instructions for storage and disposal of Esomin-LSR Capsule?
Keep this medicine in the container or the pack it came in, tightly closed. Store it according to the instructions mentioned on the pack or label. Dispose of the unused medicine. Make sure it is not consumed by pets, children and other people.
Q. What is the best time to take Esomin-LSR Capsule?
Take Esomin-LSR Capsule exactly as directed by your doctor. It is best to take one capsule daily on an empty stomach.
Q. What are the contraindications associated with the use of Esomin-LSR Capsule?
The use of Esomin-LSR Capsule should be avoided in patients with known allergy to any of the components or excipients of this medicine.
Q. Can the use of Esomin-LSR Capsule cause dizziness?
Yes, the use of Esomin-LSR Capsule can cause dizziness (feeling faint, weak, unsteady or lightheaded) in some patients. If you feel dizzy or lightheaded, it is better to rest for some time and resume once you feel better.
Q. Does the use of Esomin-LSR Capsule lead to increased risk of fractures?
Several studies in adults suggest that treatment with Esomin-LSR Capsule may be associated with an increased risk for osteoporosis-related fractures of the hip, wrist or spine. The risk of fracture was increased in patients who received high dose. High dose can mean multiple daily doses, and long-term therapy (a year or longer).